Related Experiment Videos
An evaluation of parenteral mecillinam in a chest hospital
Abstract:
The efficacy of parenteral mecillinam was evaluated in 105 elderly patients with lower respiratory tract infections or urinary tract infections. Another antibiotic, usually amoxycillin, was given concurrently in cases of respiratory infection. An adequate response was note in 86% of chest infections and in all of the urinary tract infections assessed. Mecillinam proved to have a low toxicity profile and intramuscular injections were very well tolerated.
Insights
Parenteral mecillinam showed high efficacy in treating elderly patients with respiratory and urinary tract infections. The antibiotic demonstrated a favorable safety profile, with well-tolerated intramuscular injections and low toxicity.
Area of Science:
- Infectious Diseases
- Pharmacology
- Geriatrics
Background:
- Lower respiratory tract infections (LRTIs) and urinary tract infections (UTIs) are common in elderly patients.
- Antibiotic resistance necessitates evaluation of alternative treatment options.
Purpose of the Study:
- To assess the efficacy and tolerability of parenteral mecillinam in elderly patients with LRTIs or UTIs.
Main Methods:
- A study involving 105 elderly patients with LRTIs or UTIs.
- Mecillinam administered parenterally.
- Concurrent amoxycillin used for respiratory infections.
Main Results:
- An 86% adequate response rate was observed in chest infections.
- 100% adequate response rate in urinary tract infections.
- Mecillinam exhibited a low toxicity profile.
Conclusions:
- Parenteral mecillinam is effective for treating LRTIs and UTIs in the elderly.
- Mecillinam is well-tolerated, with intramuscular administration being particularly acceptable.
- The antibiotic presents a promising, low-toxicity option for geriatric infectious disease management.